Immunovia Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Jeff Borcherding
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | n/a |
| Management average tenure | 1.1yrs |
| Board average tenure | 3.9yrs |
Recent management updates
Recent updates
CEO
Jeff Borcherding (50 yo)
less than a year
Tenure
Mr. Jeff Borcherding served as Chief Executive Officer of US, Immunovia, Inc. at Immunovia AB (publ) since 2022 until April 2023 and since April 2023 serves as its Global Chief Executive Officer and serves...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Global Chief Executive Officer & President | less than a year | no data | no data | |
| Chief Financial Officer | 2yrs | no data | no data | |
| Chief Operating Officer | 1.1yrs | no data | no data | |
| Head of Clinical & Medical Affairs | 1.2yrs | no data | no data |
1.1yrs
Average Tenure
60yo
Average Age
Experienced Management: IMMV.F's management team is not considered experienced ( 1.1 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Chairman | 3.9yrs | kr288.00k | no data | |
| Independent Director | 8.3yrs | kr280.00k | 0.10% SEK 8.7k | |
| Member of Medical Advisory Board | 7.8yrs | no data | no data | |
| Member of Medical Advisory Board | 7.8yrs | no data | no data | |
| Director | less than a year | no data | no data | |
| Independent Director | less than a year | no data | no data | |
| Member of Medical Advisory Board | 6.8yrs | no data | no data | |
| Independent Director | less than a year | no data | no data | |
| Director | 2.9yrs | kr314.00k | no data |
3.9yrs
Average Tenure
67yo
Average Age
Experienced Board: IMMV.F's board of directors are considered experienced (3.9 years average tenure).